PLI scheme envisages manufacturing of 41 Bulk Drugs with a total outlay of Rs. 6,940 cr. during the tenure of the scheme from 2020-21 to 2029-30
BHL will undertake the development and supply of these molecules
Suven Pharmaceuticals’ API and forumulations facilities complete USFDA inspection successfully
iSolveSM information on demand is the result of our focus on customer relationship
Zydus’s revenue growth was led by India and EU formulations businesses in addition to that in the emerging markets.
Developed by Pfizer, Abrocitinib has received marketing authorization from the Central Drugs Standard Control Organization (CDSCO) in India
Granules India has reported total income of Rs. 1156.23 crores during the period ended December 31, 2023
The receipt of this permission paves way for the launch of Andexanet alfa powder for solution for infusion 200 mg (Andexxa) in India
The Aptivate Champion Run witnessed an enthusiastic participation of over 4,000 Mumbaikars
Subscribe To Our Newsletter & Stay Updated
